{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,7]],"date-time":"2026-02-07T09:37:43Z","timestamp":1770457063825,"version":"3.49.0"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2026,1,20]],"date-time":"2026-01-20T00:00:00Z","timestamp":1768867200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,1,20]],"date-time":"2026-01-20T00:00:00Z","timestamp":1768867200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100010882","name":"Tianjin Municipal Education Commission","doi-asserted-by":"publisher","award":["No. 2024KJ195"],"award-info":[{"award-number":["No. 2024KJ195"]}],"id":[{"id":"10.13039\/501100010882","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Med Oncol"],"DOI":"10.1007\/s12032-026-03254-1","type":"journal-article","created":{"date-parts":[[2026,1,20]],"date-time":"2026-01-20T08:12:50Z","timestamp":1768896770000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Mechanisms of astragalus polysaccharide enhancing STM2457 therapeutic efficacy in m6A-mediated OSCC treatment"],"prefix":"10.1007","volume":"43","author":[{"given":"Xi","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,1,20]]},"reference":[{"key":"3254_CR1","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1038\/s41571-019-0227-z","volume":"16","author":"JD Cramer","year":"2019","unstructured":"Cramer JD, Burtness B, Le QT, Ferris RL. The changing therapeutic landscape of head and neck cancer. Nat Rev Clin Oncol. 2019;16:669\u201383.","journal-title":"Nat Rev Clin Oncol"},{"key":"3254_CR2","doi-asserted-by":"publisher","DOI":"10.1038\/s41368-023-00249-w","volume":"15","author":"Y Tan","year":"2023","unstructured":"Tan Y, Wang Z, Xu M, Li B, Huang Z, Qin S, et al. Oral squamous cell carcinomas: state of the field and emerging directions. Int J Oral Sci. 2023;15:44.","journal-title":"Int J Oral Sci"},{"key":"3254_CR3","doi-asserted-by":"publisher","DOI":"10.1186\/s13046-023-02618-z","volume":"42","author":"Z Huang","year":"2023","unstructured":"Huang Z, Rui X, Yi C, Chen Y, Chen R, Liang Y, et al. Silencing LCN2 suppresses oral squamous cell carcinoma progression by reducing EGFR signal activation and recycling. J Exp Clin Cancer Res. 2023;42:60.","journal-title":"J Exp Clin Cancer Res"},{"key":"3254_CR4","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2025.217482","volume":"614","author":"CS Wu","year":"2025","unstructured":"Wu CS, Li HP, Hsieh CH, Lin YT, Chang IY-F, Chung AK, et al. Integrated multi-omics analyses of oral squamous cell carcinoma reveal precision patient stratification and personalized treatment strategies. Cancer Lett. 2025;614:217482.","journal-title":"Cancer Lett"},{"key":"3254_CR5","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-022-01500-4","volume":"21","author":"Y An","year":"2022","unstructured":"An Y, Duan H. The role of m6A RNA methylation in cancer metabolism. Mol Cancer. 2022;21:14.","journal-title":"Mol Cancer"},{"key":"3254_CR6","doi-asserted-by":"publisher","first-page":"1867","DOI":"10.1007\/s12033-024-01165-y","volume":"67","author":"Y Su","year":"2025","unstructured":"Su Y, Hu Y, Qu B, Lei R, Guo G. METTL3 promotes OSCC progression by down-regulating WEE1 in a m6A-YTHDF2-dependent manner. Mol Biotechnol. 2025;67:1867\u201379.","journal-title":"Mol Biotechnol"},{"key":"3254_CR7","doi-asserted-by":"publisher","first-page":"1369","DOI":"10.1038\/nm.4416","volume":"23","author":"LP Vu","year":"2017","unstructured":"Vu LP, Pickering BF, Cheng Y, Zaccara S, Nguyen D, Minuesa G, Chou T, Chow A, Saletore Y, MacKay M, Schulman J, Famulare C, Patel M, Klimek VM, Garrett-Bakelman FE, Melnick A, Carroll M, Mason CE, Jaffrey SR, Kharas MG. The N(6)-methyladenosine (m(6)A)-forming enzyme METTL3 controls myeloid differentiation of normal hematopoietic and leukemia cells. Nat Med. 2017;23:1369\u201376.","journal-title":"Nat Med"},{"key":"3254_CR8","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-019-1038-7","volume":"18","author":"T Li","year":"2019","unstructured":"Li T, Hu PS, Zuo Z, Lin JF, Li X, Wu QN, et al. METTL3 facilitates tumor progression via an m(6)A-IGF2BP2-dependent mechanism in colorectal carcinoma. Mol Cancer. 2019;18:112.","journal-title":"Mol Cancer"},{"key":"3254_CR9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.omtn.2020.01.033","volume":"20","author":"W Zhao","year":"2020","unstructured":"Zhao W, Cui Y, Liu L, Ma X, Qi X, Wang Y, et al. METTL3 facilitates oral squamous cell carcinoma tumorigenesis by enhancing c-Myc stability via YTHDF1-mediated m(6)A modification. Mol Ther Nucleic Acids. 2020;20:1\u201312.","journal-title":"Mol Ther Nucleic Acids"},{"key":"3254_CR10","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.716921","volume":"11","author":"F Zhu","year":"2021","unstructured":"Zhu F, Yang T, Yao M, Shen T, Fang C. HNRNPA2B1, as a m(6)A reader, promotes tumorigenesis and metastasis of oral squamous cell carcinoma. Front Oncol. 2021;11:716921.","journal-title":"Front Oncol"},{"key":"3254_CR11","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-34239-z","volume":"13","author":"AV Mitchell","year":"2022","unstructured":"Mitchell AV, Wu L, Craig DB, Chen W, Dou Y, Gibson H, et al. FOXQ1 recruits the MLL complex to activate transcription of EMT and promote breast cancer metastasis. Nat Commun. 2022;13:6548.","journal-title":"Nat Commun"},{"key":"3254_CR12","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2023.216144","volume":"560","author":"D Xiang","year":"2023","unstructured":"Xiang D, Gu M, Liu J, Dong W, Yang Z, Wang K, et al. M6a rna methylation-mediated upregulation of HLF promotes intrahepatic cholangiocarcinoma progression by regulating the FZD4\/\u03b2-catenin signaling pathway. Cancer Lett. 2023;560:216144.","journal-title":"Cancer Lett"},{"key":"3254_CR13","doi-asserted-by":"publisher","first-page":"1299","DOI":"10.1016\/j.cell.2015.08.011","volume":"162","author":"CR Alarc\u00f3n","year":"2015","unstructured":"Alarc\u00f3n CR, Goodarzi H, Lee H, Liu X, Tavazoie S, Tavazoie SF. HNRNPA2B1 is a mediator of m(6)A-Dependent nuclear RNA processing events. Cell. 2015;162:1299\u2013308.","journal-title":"Cell"},{"key":"3254_CR14","doi-asserted-by":"publisher","DOI":"10.1016\/j.archoralbio.2025.106403","volume":"180","author":"PA K","year":"2025","unstructured":"K PA, Usman PPA, Sekar D. Oip5-as1 expression profiles in different stages of oral squamous cell carcinoma. Arch Oral Biol. 2025;180:106403.","journal-title":"Arch Oral Biol"},{"key":"3254_CR15","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.placenta.2024.09.018","volume":"158","author":"SC Selvakumar","year":"2024","unstructured":"Selvakumar SC, Preethi KA, Ross K, Sekar D. The emerging role of microrna-based therapeutics in the treatment of preeclampsia. Placenta. 2024;158:38\u201347.","journal-title":"Placenta"},{"key":"3254_CR16","doi-asserted-by":"publisher","first-page":"37","DOI":"10.23736\/S2724-6329.23.04840-4","volume":"73","author":"P Thomas","year":"2024","unstructured":"Thomas P, Selvakumar SC, Preethi KA, Sekar D. Expression profiling of signal transducer and activator of transcription3 in oral squamous cell carcinoma in South Indian population. Minerva Dent Oral Sci. 2024;73:37\u201344.","journal-title":"Minerva Dent Oral Sci"},{"key":"3254_CR17","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1038\/s41586-021-03536-w","volume":"593","author":"E Yankova","year":"2021","unstructured":"Yankova E, Blackaby W, Albertella M, Rak J, De Braekeleer E, Tsagkogeorga G, et al. Small-molecule inhibition of METTL3 as a strategy against myeloid leukaemia. Nature. 2021;593:597\u2013601.","journal-title":"Nature"},{"key":"3254_CR18","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-025-07560-w","volume":"16","author":"CQ Jiao","year":"2025","unstructured":"Jiao CQ, Hu C, Sun MH, Li Y, Wu C, Xu F, et al. Targeting METTL3 mitigates venetoclax resistance via proteasome-mediated modulation of MCL1 in acute myeloid leukemia. Cell Death Dis. 2025;16:233.","journal-title":"Cell Death Dis"},{"key":"3254_CR19","doi-asserted-by":"publisher","DOI":"10.1186\/s13046-023-02638-9","volume":"42","author":"Y Sun","year":"2023","unstructured":"Sun Y, Shen W, Hu S, Lyu Q, Wang Q, Wei T, et al. METTL3 promotes chemoresistance in small cell lung cancer by inducing mitophagy. J Exp Clin Cancer Res. 2023;42:65.","journal-title":"J Exp Clin Cancer Res"},{"key":"3254_CR20","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2023.216122","volume":"559","author":"L Wang","year":"2023","unstructured":"Wang L, Yang Q, Zhou Q, Fang F, Lei K, Liu Z, et al. METTL3-m(6)A-EGFR-axis drives lenvatinib resistance in hepatocellular carcinoma. Cancer Lett. 2023;559:216122.","journal-title":"Cancer Lett"},{"key":"3254_CR21","doi-asserted-by":"publisher","first-page":"4243","DOI":"10.1111\/odi.14864","volume":"30","author":"L Liu","year":"2024","unstructured":"Liu L, Zhao T, Zheng S, Tang D, Han H, Yang C, Zheng X, Wang J, Ma J, Wei W, Wang Z, He S, He Q. METTL3 inhibitor STM2457 impairs tumor progression and enhances sensitivity to anlotinib in OSCC. Oral Dis. 2024;30:4243\u201354.","journal-title":"Oral Dis"},{"key":"3254_CR22","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijbiomac.2023.124386","volume":"241","author":"G Chen","year":"2023","unstructured":"Chen G, Jiang N, Zheng J, Hu H, Yang H, Lin A, et al. Structural characterization and anti-inflammatory activity of polysaccharides from astragalus membranaceus. Int J Biol Macromol. 2023;241:124386.","journal-title":"Int J Biol Macromol"},{"key":"3254_CR23","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1016\/j.ijbiomac.2019.09.189","volume":"145","author":"W Li","year":"2020","unstructured":"Li W, Hu X, Wang S, Jiao Z, Sun T, Liu T, et al. Characterization and anti-tumor bioactivity of astragalus polysaccharides by immunomodulation. Int J Biol Macromol. 2020;145:985\u201397.","journal-title":"Int J Biol Macromol"},{"key":"3254_CR24","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijbiomac.2025.143739","volume":"311","author":"R Chen","year":"2025","unstructured":"Chen R, Li Y, Zuo L, Xiong H, Sun R, Song X, et al. Astragalus polysaccharides inhibits tumor proliferation and enhances cisplatin sensitivity in bladder cancer by regulating the PI3K\/AKT\/FoxO1 axis. Int J Biol Macromol. 2025;311:143739.","journal-title":"Int J Biol Macromol"},{"key":"3254_CR25","doi-asserted-by":"publisher","first-page":"e0271598","DOI":"10.1371\/journal.pone.0271598","volume":"17","author":"J Fan","year":"2022","unstructured":"Fan J, Jia F, Liu Y, Zhou X. Astragalus polysaccharides and Astragaloside IV alleviate inflammation in bovine mammary epithelial cells by regulating Wnt\/\u03b2-catenin signaling pathway. PLoS One. 2022;17:e0271598.","journal-title":"PLoS One"},{"key":"3254_CR26","doi-asserted-by":"publisher","DOI":"10.3390\/polym15183659","author":"H Chen","year":"2023","unstructured":"Chen H, Hu Y, Wu C, Liu K, Feng R, Yang M, et al. Mesoporous titanium dioxide nanoparticles-poly(N-isopropylacrylamide) hydrogel prepared by electron beam irradiation inhibits the proliferation and migration of oral squamous cell carcinoma cells. Polymers (Basel). 2023. https:\/\/doi.org\/10.3390\/polym15183659.","journal-title":"Polymers (Basel)"},{"key":"3254_CR27","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1002\/iub.2808","volume":"76","author":"X Wang","year":"2024","unstructured":"Wang X, Zhi M, Zhao W, Deng J. HNRNPA2B1 promotes oral squamous cell carcinogenesis via m(6)A-dependent stabilization of FOXQ1 mRNA stability. IUBMB Life. 2024;76:437\u201350.","journal-title":"IUBMB Life"},{"key":"3254_CR28","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.1023878","volume":"13","author":"H Long","year":"2022","unstructured":"Long H, Lin H, Zheng P, Hou L, Zhang M, Lin S, et al. WTAP mediates the anti-inflammatory effect of Astragalus mongholicus polysaccharide on THP-1 macrophages. Front Pharmacol. 2022;13:1023878.","journal-title":"Front Pharmacol"},{"key":"3254_CR29","doi-asserted-by":"publisher","DOI":"10.1093\/toxres\/tfae099","volume":"13","author":"W Cui","year":"2024","unstructured":"Cui W, Jin Z, Chen G, Cheng Y, Lin H, Wang B. Astragalus polysaccharide alleviates IL-13-induced oxidative stress injury in nasal epithelial cells by inhibiting WTAP-mediated FBXW7 m(6)A modification. Toxicol Res (Camb). 2024;13:tfae099.","journal-title":"Toxicol Res (Camb)"},{"key":"3254_CR30","doi-asserted-by":"publisher","first-page":"2130","DOI":"10.1080\/10717544.2022.2094498","volume":"29","author":"B Li","year":"2022","unstructured":"Li B, Shao H, Gao L, Li H, Sheng H, Zhu L. Nano-drug co-delivery system of natural active ingredients and chemotherapy drugs for cancer treatment: a review. Drug Deliv. 2022;29:2130\u201361.","journal-title":"Drug Deliv"},{"key":"3254_CR31","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-022-01558-0","volume":"21","author":"X Li","year":"2022","unstructured":"Li X, Ma S, Deng Y, Yi P, Yu J. Targeting the RNA m(6)A modification for cancer immunotherapy. Mol Cancer. 2022;21:76.","journal-title":"Mol Cancer"},{"key":"3254_CR32","doi-asserted-by":"publisher","DOI":"10.1186\/s13578-025-01368-z","volume":"15","author":"T Shi","year":"2025","unstructured":"Shi T, Zhang H, Chen Y. The m6A revolution: transforming tumor immunity and enhancing immunotherapy outcomes. Cell Biosci. 2025;15:27.","journal-title":"Cell Biosci"},{"key":"3254_CR33","doi-asserted-by":"publisher","first-page":"1388","DOI":"10.1158\/2767-9764.CRC-22-0013","volume":"2","author":"AV Mitchell","year":"2022","unstructured":"Mitchell AV, Wu J, Meng F, Dong L, Block CJ, Song WM, Zhang B, Li J, Wu G. DDR2 coordinates EMT and metabolic reprogramming as a shared effector of FOXQ1 and SNAI1. Cancer Res Commun. 2022;2:1388\u2013403.","journal-title":"Cancer Res Commun"},{"key":"3254_CR34","doi-asserted-by":"publisher","first-page":"11667","DOI":"10.18632\/aging.103333","volume":"12","author":"GZ Huang","year":"2020","unstructured":"Huang GZ, Wu QQ, Zheng ZN, Shao TR, Chen YC, Zeng WS, Lv XZ. M6A-related bioinformatics analysis reveals that HNRNPC facilitates progression of OSCC via EMT. Aging. 2020;12:11667\u201384.","journal-title":"Aging"},{"key":"3254_CR35","doi-asserted-by":"publisher","first-page":"e39937","DOI":"10.1371\/journal.pone.0039937","volume":"7","author":"J Feng","year":"2012","unstructured":"Feng J, Zhang X, Zhu H, Wang X, Ni S, Huang J. FoxQ1 overexpression influences poor prognosis in non-small cell lung cancer, associates with the phenomenon of EMT. PLoS One. 2012;7:e39937.","journal-title":"PLoS One"},{"key":"3254_CR36","first-page":"1573","volume":"32","author":"L Haizhao","year":"2024","unstructured":"Haizhao L, Yutong J, Ruixuan Z, Yi H, Yuhong B. A preliminary investigation of the mechanism of the anti-lung adenocarcinoma effect of astragalus polysaccharide by modulating T cell sensitization of PD-L1 blockers. J Mod Oncol. 2024;32:1573\u201380.","journal-title":"J Mod Oncol"},{"key":"3254_CR37","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2024.114369","volume":"43","author":"S Garbo","year":"2024","unstructured":"Garbo S, D\u2019Andrea D, Colantoni A, Fiorentino F, Mai A, Ramos A, et al. M6A modification inhibits miRNAs\u2019 intracellular function, favoring their extracellular export for intercellular communication. Cell Rep. 2024;43:114369.","journal-title":"Cell Rep"},{"key":"3254_CR38","doi-asserted-by":"publisher","DOI":"10.3390\/ph17050636","author":"Z He","year":"2024","unstructured":"He Z, Liu X, Qin S, Yang Q, Na J, Xue Z, et al. Anticancer mechanism of Astragalus polysaccharide and its application in cancer immunotherapy. Pharmaceuticals (Basel). 2024. https:\/\/doi.org\/10.3390\/ph17050636.","journal-title":"Pharmaceuticals (Basel)"},{"key":"3254_CR39","doi-asserted-by":"publisher","first-page":"11705","DOI":"10.1007\/s00210-025-04074-2","volume":"398","author":"Q Li","year":"2025","unstructured":"Li Q, Li J, Wang Y, Wu F, Li T. Efficacy and safety of astragalus polysaccharides in patients with malignant tumors: a systematic review and meta-analysis. Naunyn Schmiedebergs Arch Pharmacol. 2025;398:11705\u201332.","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"3254_CR40","doi-asserted-by":"publisher","DOI":"10.1002\/ctm2.70089","volume":"14","author":"K Wu","year":"2024","unstructured":"Wu K, Li S, Hong G, Dong H, Tang T, Liu H, et al. Targeting METTL3 as a checkpoint to enhance T cells for tumour immunotherapy. Clin Transl Med. 2024;14:e70089.","journal-title":"Clin Transl Med"},{"key":"3254_CR41","doi-asserted-by":"publisher","first-page":"2586","DOI":"10.1038\/s41375-022-01696-w","volume":"36","author":"M Li","year":"2022","unstructured":"Li M, Ye J, Xia Y, Ji C, Li M, Li G, Hu X, Su X, Wang D, Zhao X, Lu F, Li J, Ma D, Sun T. METTL3 mediates chemoresistance by enhancing AML homing and engraftment via ITGA4. Leukemia. 2022;36:2586\u201395.","journal-title":"Leukemia"},{"key":"3254_CR42","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1158\/1541-7786.MCR-24-0362","volume":"23","author":"W Chen","year":"2025","unstructured":"Chen W, Zhang J, Liu N, Ma W, Wu T. METTL3-mediated m6A modification regulates the polycomb repressive complex 1 components BMI1 and RNF2 in hepatocellular carcinoma cells. Mol Cancer Res. 2025;23:190\u2013201.","journal-title":"Mol Cancer Res"},{"key":"3254_CR43","doi-asserted-by":"publisher","first-page":"38668","DOI":"10.1039\/D4RA07193J","volume":"14","author":"B Tang","year":"2024","unstructured":"Tang B, Huang R, Ma W. Advances in nanotechnology-based approaches for the treatment of head and neck squamous cell carcinoma. RSC Adv. 2024;14:38668\u201388.","journal-title":"RSC Adv"},{"key":"3254_CR44","doi-asserted-by":"publisher","first-page":"4837","DOI":"10.18632\/oncotarget.13596","volume":"8","author":"Y Cao","year":"2017","unstructured":"Cao Y, Shen T, Huang X, Lin Y, Chen B, Pang J, Li G, Wang Q, Zohrabian S, Duan C, Ruan Y, Man Y, Wang S, Li J. Astragalus polysaccharide restores autophagic flux and improves cardiomyocyte function in doxorubicin-induced cardiotoxicity. Oncotarget. 2017;8:4837\u201348.","journal-title":"Oncotarget"}],"container-title":["Medical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12032-026-03254-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12032-026-03254-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12032-026-03254-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,6]],"date-time":"2026-02-06T16:04:29Z","timestamp":1770393869000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12032-026-03254-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,20]]},"references-count":44,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2026,2]]}},"alternative-id":["3254"],"URL":"https:\/\/doi.org\/10.1007\/s12032-026-03254-1","relation":{},"ISSN":["1559-131X"],"issn-type":[{"value":"1559-131X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,20]]},"assertion":[{"value":"1 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The author agrees with the publication.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}],"article-number":"122"}}